About
Welcome to my corner of the Life Sciences world, where I specialize in taking on the most…
Articles by Srinivas
-
Benefits of Orphan Drug Designation (ODD) and managing Clinical Trials?
Benefits of Orphan Drug Designation (ODD) and managing Clinical Trials?
By Srinivas Chilukuri
-
Mental conditioning and a continuous pursuit to be top class in your profession
Mental conditioning and a continuous pursuit to be top class in your profession
By Srinivas Chilukuri
Activity
-
When seconds count, the right medical device can make all the difference. At Kaleidoscope Innovation, we partnered with NPXe, a pioneering startup…
When seconds count, the right medical device can make all the difference. At Kaleidoscope Innovation, we partnered with NPXe, a pioneering startup…
Liked by Srinivas Chilukuri
-
Infosys is delighted to introduce Veeva Amplifier from BASE Life Science, an Infosys company, which marks a transformative milestone in the journey…
Infosys is delighted to introduce Veeva Amplifier from BASE Life Science, an Infosys company, which marks a transformative milestone in the journey…
Liked by Srinivas Chilukuri
-
94% of the life sciences firms we surveyed plan to increase spending on digital therapeutics in the next 2 years. Full report:…
94% of the life sciences firms we surveyed plan to increase spending on digital therapeutics in the next 2 years. Full report:…
Liked by Srinivas Chilukuri
Experience
Education
Licenses & Certifications
Recommendations received
1 person has recommended Srinivas
Join now to viewMore activity by Srinivas
-
I couldn’t be prouder to announce that we have been named to the ‘Best Firms to Work For’ 2024 list by Consulting Magazine. This prestigious…
I couldn’t be prouder to announce that we have been named to the ‘Best Firms to Work For’ 2024 list by Consulting Magazine. This prestigious…
Liked by Srinivas Chilukuri
-
I am humbled to share that I have recently been inducted into my high school's Athletic Hall of Fame. This would not have been possible without all…
I am humbled to share that I have recently been inducted into my high school's Athletic Hall of Fame. This would not have been possible without all…
Liked by Srinivas Chilukuri
-
In our new blog post, Rajendra Prasad Kaluvala explains how critical managing vast amounts of regulatory information is in today's highly regulated…
In our new blog post, Rajendra Prasad Kaluvala explains how critical managing vast amounts of regulatory information is in today's highly regulated…
Liked by Srinivas Chilukuri
-
A pleasure to be part of this great organization and to serve as a reviewer at the upcoming ASCPT 2025 #ASCPT2025, #IamASCPT…
A pleasure to be part of this great organization and to serve as a reviewer at the upcoming ASCPT 2025 #ASCPT2025, #IamASCPT…
Liked by Srinivas Chilukuri
-
CRS Conference in Bologna, Italy was a success. The conference was sold out (~2000 scientists). Had a nice podium pitch presentation and several…
CRS Conference in Bologna, Italy was a success. The conference was sold out (~2000 scientists). Had a nice podium pitch presentation and several…
Liked by Srinivas Chilukuri
-
I'm thrilled to announce that Infosys Consulting has secured the #2 spot in the Top 50 Consulting Firms list for 2024 by The Consulting Report. This…
I'm thrilled to announce that Infosys Consulting has secured the #2 spot in the Top 50 Consulting Firms list for 2024 by The Consulting Report. This…
Liked by Srinivas Chilukuri
-
World-First CAR T-Cell Therapy for Child With Lupus: In a groundbreaking medical achievement, #CART #CellTherapy has been used for the first time…
World-First CAR T-Cell Therapy for Child With Lupus: In a groundbreaking medical achievement, #CART #CellTherapy has been used for the first time…
Liked by Srinivas Chilukuri
-
Very happy to share my interview with #Priyanka Haldipur from the Infosys Knowledge Institute about how Infosys is helping a large global retailer…
Very happy to share my interview with #Priyanka Haldipur from the Infosys Knowledge Institute about how Infosys is helping a large global retailer…
Liked by Srinivas Chilukuri
-
I will talk at the 5th gamma-delta T cells summit on our novel technology to generate off-the-shelf CAR-gdT cells using CRISPR and AAV. We believe…
I will talk at the 5th gamma-delta T cells summit on our novel technology to generate off-the-shelf CAR-gdT cells using CRISPR and AAV. We believe…
Liked by Srinivas Chilukuri
-
$𝟮𝟬𝗯𝗶𝗹𝗹𝗶𝗼𝗻 𝗱𝗲𝗮𝗹𝘀 𝗶𝗻 𝟲 𝗺𝗼𝗻𝘁𝗵𝘀! CGT collabs are leading the way 👇 In H1 2024, strategic collaborations in Cell and Gene…
$𝟮𝟬𝗯𝗶𝗹𝗹𝗶𝗼𝗻 𝗱𝗲𝗮𝗹𝘀 𝗶𝗻 𝟲 𝗺𝗼𝗻𝘁𝗵𝘀! CGT collabs are leading the way 👇 In H1 2024, strategic collaborations in Cell and Gene…
Liked by Srinivas Chilukuri
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Srinivas Chilukuri in United States
-
Srinivas Chilukuri
-
Srinivas Chilukuri
President and CEO at Konark Inc
-
Srinivas Chilukuri
Systems Engineer - Integration Center of Excellence
-
Srinivas Chilukuri
15 others named Srinivas Chilukuri in United States are on LinkedIn
See others named Srinivas Chilukuri